Determinants of Patient Delay in Doctor Consultation in Oeso-gastric Cancers

Not Applicable

Active, not recruiting

• Conditions: Oesophageal Carcinoma; Gastric Adenocarcinoma
• Interventions: Other: Questionnaire

• Registration Number: NCT03246516
• Lead Sponsor: University Hospital, Lille

Brief Summary

This study evaluates the role of socioeconomic and individual factors in the onset of the first symptoms of cancer and the first consultation with a doctor (patient delay) in oeso-gastric cancer.

Detailed Description

Reducing the time between the onset of the first symptoms of cancer and the first consultation with a doctor (patient delay) is essential to improve the vital prognosis and quality of life of patients. Recent data suggest that some sociocognitive and emotional determinants may explain patient delay from a complementary point of view. The main objective of this study is to assess whether, in oeso-gastric cancer, patient delay is linked to these sociocognitive and emotional factors, in addition to previously known factors.

We intend to include in this study 300 patients with a not yet treated oeso-gastric cancer diagnosed in one of 10 health centres in the North of France region. The collected data will be analysed to underline the differences between patients who consulted a doctor earlier versus those who consulted later with a cut off at 8 weeks.

Study Timeline

• Study Start: 2017-02-01
• Study First Submitted: 2017-08-08
• Study First Submitted QC: 2017-08-08
• Study First Posted: 2017-08-11
• Status Verified: 2022-10
• Last Update Submitted: 2022-10-21
• Last Update Posted: 2022-10-24
• Primary Completion: 2025-05
• Study Completion: 2025-05

Recruitment & Eligibility

• Status: ACTIVE_NOT_RECRUITING
• Sex: All
• Target Recruitment: 258

Inclusion Criteria

• age ≥ 18 years
• oesophageal, oeso-gastric junction or gastric cancer non treated cancer
• patient informed of his diagnosis
• speak fluent french

Exclusion Criteria

• history of cancer
• psychological history
• patient under guardianship-
• fortuitous diagnosis of cancer

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
Questionnaire	Questionnaire	Auto and hetero questionnaire

Primary Outcome Measures

Name	Time	Method
Time limit of first doctor consultation	baseline	Median time between date of symptoms appearance and date of first consultation

Secondary Outcome Measures

Name	Time	Method
Emotional variables	baseline	Emotional variables associated with time of first doctor consultation
Time limit of system of care	baseline	Median time between date of he beginning of clinical investigations and the beginning of treatment
Socio-cognitive variables	baseline	Socio-cognitive variables associated with time of first doctor consultation
cTNM Stage	baseline	Stage TNM by distinguishing the early stages (I, II) vs. (III, IV)
clinical variables (i.e medical history, symptoms, entry into care pathway)	baseline	clinical variables associated with time of first doctor consultation
Survival	At 3 years

Trial Locations

Locations (10)

Centre Hospitalier de Boulogne sur mer; 🇫🇷 Boulogne-sur-Mer, France

Centre hospitalier de Calais; 🇫🇷 Calais, France

Centre hospitalier de Béthune; 🇫🇷 Béthune, France

Centre d 'oncologie Dunkerquois; 🇫🇷 Dunkerque, France

centre Léonard de Vinci; 🇫🇷 Dechy, France

Centre oscar Lambret; 🇫🇷 Lille, France

CHRU, Hôpital Claude Huriez; 🇫🇷 Lille, France

Centre hospitalier de Roubaix; 🇫🇷 Roubaix, France

Centre Hospitalier de Seclin; 🇫🇷 Seclin, France

Centre hospitalier de valenciennes; 🇫🇷 Valenciennes, France